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Mast cells (MC) l are widely distributed throughout vascularized tissues and cer-
tain epithelia. They representa source ofpotent mediators ofinflammation (reviewed
in references 1-4) . These mediators are released after sensitization with IgE immu-
noglobulins, which are bound to IgE receptors (FceRI) on the MC, andcrosslinking
with specific multivalent antigen (4) . Such activation causes MC to degranulate
releasing histamine, heparin, andothersulphated proteoglycansand certain neutral
proteases . ActivatedMC also elaborate newly synthesized mediators such as prod-
ucts of the cyclooxygenase and lipoxygenase pathways of arachidonic acid metabo-
lism (reviewed in references 2-4) . MC are widely regarded as critical effector cells
in the inflammatory reactions underlying disorders of IgE-dependent immediate
hypersensitivity andin theexpression ofprotective immunity involvingIgE (reviewed
in references 1-4).
Studies in mice indicate thatMC are derived from multipotential bone marrow-
derived hematopoietic precursors which complete their program of differentiation
and maturation in vascularized tissues, epithelia, and serosal cavities (reviewed in
references 1, 5) . This process results in the generation ofmast cell populations which
vary in multiple aspects of their phenotype, including morphology, mediator con-
tent, and sensitivity to regulation by cytokines affecting proliferation and matura-
tion (reviewed in reference 1) . One such population, referred to as "mucosal" mast
cells (MMC) because they occur in the mucosal layer of gastrointestinal tissues, ap-
pears to be exquisitely sensitive to regulation by theT cell-associated cytokines IL-3
and IL-4 (1) . IL-3 probably represents the major cytokine regulating proliferation
ofthis subset (6, 7), whereas in vitrostudies indicate that IL-4 can act as a costimulant
of proliferation (8) . Thus, the mouseMMC population is regulated by products
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of the same CD4+ T cells (9, 10), which, through production of IL-4, critically regu-
late the generation of the IgE response (11).
Techniques for purifying mouse MMC have not been described. However, IL-3-
dependent mouse MC which share many phenotypic characteristics with MMC can
be generated from normal mouse hematopoietic cells in vitro and these primary MC
cultures can be used to isolate cloned MC lines of similar phenotype (1, 12, 13) .
Such clones may spontaneously become IL-3-independent (14, 15). IL-3-independent
mouse MG lines can also be generated by infecting mouse hematopoietic cells with
Abelson murine leukemia virus (AbMuLV) (16-19). Studies of AbMuLVtransformed
MC lines indicate that some of these populations transcribe mRNA and/or release
GM-CSF (17, 18, 20), IL-3 (18, 20), IL-4 (18), and IL-6 (20). Moreover, some un-
stimulated IL-3-dependent MC lines transcribe low levels of IL-4 mRNA, but do
not secrete detectable levels of IL-4 (18).
In addition, Younget al. (14) reported that several IL-3-dependent and -independent
mouse MC clones, as well as freshly isolated peritoneal MC, contain and secrete
upon stimulation a protein with many immunological and functional characteristics
of the monocyte/macrophage-associated cytokine TNFa (cachectin). Richards et
al. (21) showed that a rat basophilic leukemia cell line also produced a TNFa-like
cytolytic agent, and that release of this activity could be enhanced by stimulation
of the cells with IgE and specific antigen. Plaut et al. (22) reported that stimulation
with IgE and antigen induced gene expression and/or secretion ofIL-3, IL-4, IL-5,
and IL-6 in IL-3-dependent mast cell lines.
Taken together, the observations about MC-derived activities previously regarded
as characteristic of T cells or monocytes/macrophages raised the possibility that MC
might represent an important alternative source of cytokines during IgE-mediated
immunological and inflammatory responses. We therefore assessed RNA levels after
activation with IgE plus antigen for a large panel of T cell and/or monocyte/macro-
phage-associated cytokine genes in both IL-3-dependent and -independent mouse
MC populations. We found that growth factor-dependent and -independent MC
lines can be induced to transcribe a variety ofcytokine genes and secrete their prod-
ucts in response to activation via specific crosslinking of FceRl . These data suggest
that during IgE-mediated hypersensitivity responses, MC may serve as a potent source
ofgrowth, regulatory, and inflammatory agents having abroad range ofbiologic effects.
Materials and Methods
Cell Lines and Tissue Culture.
￿
Cl.MC/2D4 and CI.MC/C57.1 are cloned growth factor-in-
dependent mast cell lines derived from BALB/c mouse spleen cells and C57BL/6J mouse
bone marrow cells respectively (14). PT18 is a growth factor-dependent cell line derived from
C3H.SW mouse spleen cells (23). C1.MC/9 is a growth factor-dependent MC line derived
from a 13 d (C57BL/6J x A/J) Fl fetus (12, 13). The C1.MC/9 cells used for this work were
recently (N4 mo before this study) grown from stocks frozen in 1982. CI.MC/9. 2 is a growth
factor-dependent subline of Cl.MC/9 obtained from D. Rennick (DNAX Research Insti-
tute, Palo Alto, CA) (24) that has been maintained in continuous culture. All cell lines were
periodically monitored for growth factor dependence or independence and were assessed for
maintenance of the mast cell phenotype by light and electron microscopic examination and
analysis of histamine content.
Growth factor-containing cell culture supernatants for maintenance ofthe factor-dependent
MC lines were generated by 24-h Con A (4 kg/ml) stimulation ofD10.G4 cells (25). CI.MC/9,BURD ET AL.
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C1.MC9.2, and PT-18 cells were maintained routinely in factor-conditioned medium (5%
Con A-stimulated D10.G4 cell supernatant, 10% FCS, and 5 x 10-5 M 2-ME in DMEM
(Gibco Laboratories, Grand Island, NY)). Thefactor-independent cell linesC1.MC/2D4and
C1.MC/C57.1 were maintained in 10% FCS and 5 x 10-5 M 2-ME in DMEM (Gibco
Laboratories). IL-3-dependent bone marrow-derived cultured MC (BMCMC) were derived
as indicated previously (12, 13), andwere maintained in 20% ConA-stimulated murine spleen
cell-conditioned medium, 10% FCS, and 5 x 10-5 M 2-ME in DMEM. Cells harvested for
RNA (or DNA) analysis were stimulated for 4 h at a density of 3 x 106 cells/ml in the cul-
ture medium routinely used formaintenance ofthat cell population. Wherenoted, cells were
stimulated in the presence of cyclosporin A (2 ug/ml) or cycloheximide (10 ug/ml) (Sigma
Chemical Co., St. Louis, MO). Cell supernatants for bioassay were obtained after 24 h of
culture in 5olo FCS in RPMI 1640 (CI.MC/9) or DMEM (C1.MC/C57.1, BMCMC) with
an initial culture density of 106 cells/ml.
Where noted, MC were stimulated with 50 ng/ml PMA (stock 10 pg/ml in acetone), 2.5
leg/ml ConA (stock 400 wg/mlin RPMI), or 100ng/ml A23187 (stock 110 leg/ml in DMSO).
Monoclonal IgE anti-DNP-producing hybridomaH1-DNP-E-26 (26) wasgenerously provided
by Drs. F. T Liu andD. H. Katz (Molecular Biology Institute, La Jolla, CA) andwas used
to generate ascites. MC were sensitized with the ascites at a final concentration equivalent
to 3 Ag IgE anti-DNP/ml cells. MC were incubated for 30 min at room temperature with
IgE antibody, washed with medium, then resuspended with medium containing DNP30-40-
HSA (10 ng/ml; SigmaChemical Co., St. Louis, MO). These conditions of stimulation were
shown previously to be adequate for inducing degranulation andmediator release from these
clones (12, 27, 28).
Northern Blot Analysis.
￿
Total cellular RNA was isolated by guanidine thiocyanate/cesium
chloride gradient centrifugation as described elsewhere (29). 20 ug RNA was denatured in
50%o formamideand 2.2 M formaldehyde, fractionated on 1.2% agarose gels, and transferred
to nylon-reinforced nitrocellulose (MSI, Westboro, MA) as described (30). RNA sizes were
determined by comparison to RNA size markers obtained from Bethesda Research Labora-
tories, Gaithersburg, MD.
Hybridizations were performed at 37-42°C in 50% formamide, 5x Denhardt's solution,
0.66 M NaCl, 0.09 M NaP04 (pH 7.0), 0.4 mM Na3EDTA, 0.09 M sodium pyrophosphate,
0.3% SDS, and 130gg/ml sonicated, denaturedherring spermDNA. Hybridized blotswere
washed in 30 mM NaCl and 3 mM sodium citrate (pH 7.0), containing 0.25 mM Na3EDTA,
0.02 M NaP04, and 0.1% SDS.
cDNA Probes.
￿
Cytokines probes were obtained as follows: murine IL-Ix wasagift of Drs.
P Lomedico andU. Grubler(Hoffman LaRoche, Nutley, NJ)(31), murine IL-3 and IFN-ywere
agift ofDr. G. Freeman (Dana-Farber Cancer Institute, Boston, MA)(32),JE (33) wasagift of
Dr. B. Rollins (Dana-Farber Cancer Institute, Boston, MA), IL-5, IL-6 (34) and granulo-
cyte/macrophage CSF(GM-CSF) (35) were obtained from Dr. S. Clark(Genetics Institute,
Cambridge, MA), MIPlcdTY5 (36, 37) and MIPlß/mH400 (37, 38)were giftsofDr. G. Zur-
waski (DNAX Research Institute, Palo Alto, CA) (Note that TY5 and mH400 are referred
to as MIPla and MIP1ß in this study), and TCA3 was cloned in this laboratory (39).
cDNA inserts were excisedby restriction digestionandtwicegel purified by NaI/glasstreat-
ment accordingto the recommendations ofthemanufacturer (Bio 101, LaJolla, CA). Probes
were labeled by random hexamer priming using protocols and reagents suggested by the
manufacturer (Bethesda Research Laboratories, Gaithersburg, MD).
Bioassays.
￿
All thebioassayswere performed in 96-well flat-bottomed microplates (Falcon
Labware, Oxnard, CA) in 0.2 ml medium. IL-1 production was measured by the D10.G4.1
proliferation assay in the presence ofCon Aas described(25, 40). IL-4 bioactivity was mea-
sured by assaying the proliferative effects of MC supernatants on the HT-2 cell line. IL-4
specificity was confirmed by antibody inhibition; supernatants were incubated with HT-2
cells in the presence of 1:200 dilution of ascites from anti-IL-4 hybridoma 11B11 (41; a gift
of Dr. W Paul, National Institutes of Health, Bethesda, MD). IL-6 activity was measured
usingthe IL-6-dependent myeloma cell line T1165tc as described elsewhere (42). IL-1, IL-4,
and IL-6 activities are reported as cpm of target cell proliferation.248
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Results
Stimulation ofMast Cells via the FCERILeads to Cytokine Gene Expression .
￿
We exam-
ined in unstimulated MC and in MC activated via FceRI the transcription levels
of a number of cytokine and T cell activation-associated genes. Three growth
factor-dependent (C1.MC/9, C1.MC/9.2, and PT-18) and one growth factor-inde-
pendent (C1.MC/C57.1) MC clones were analyzed . Cells were incubated with IgE
for 30 min, washed to remove unbound antibody, exposed to specific antigen for
4 h, and harvested for Northern analysis . Unstimulated (resting) cells not incubated
with IgE and antigen were also analyzed . Although absolute levels of RNA were
not quantitated, when all four lines were tested on the same blot, relative amounts
ofRNA could be assessed . Actin was used to verify the integrity of the RNA . Our
decision to examine transcription at 4 h after stimulation was based on observations
that many T cell-specific genes transcribed in response to cellular activating stimuli
are "early genes" and are detectable as soon as 1-2 h after stimulation (29, 43), and
on observations that stimulation ofMC lines with IgE and antigen for 4 h greatly
augments expression of TNFci RNA (Gordon, J . R ., and S . J . Galli, unpublished
observations) .
Cl.MC/9 expressed all but one (IFN--y) of the genes tested in response to activa-
tion by IgE and antigen (Fig . 1), but before activation only low levels ofJE were
detectable (Fig . 2) . CI.MC/9 . 2 transcribed lower levels of these genes (except for
IL-1, IL-3, and JE, which could not be detected) in response to FceRI signaling
and did not express any of the genes before activation . In contrast, only IL-5, IL-6,
and IFN-,yRNA were detected in the PT-18 cell line after activation (Fig . 1) . IL-6
RNA was also present in untreated PT-18 cells and expression of IL-6 RNA was
not significantly enhanced by activation of PT18 cells (data not shown). Each of
the tested genes was induced in the growth factor-independent cell line C1.MC/C57 .1 .
However, low levels of IL-6 (Fig . 3) and JE (data not shown) were also expressed
in resting C1.MC/C57 .1 cells . In separate experiments using another growth factor-
independent MC clone, Cl.MC/2D4, we observed activation specific expression of
the three lymphokine genes tested, i.e ., IL-1, IL-6, and TCA3 (data not shown) .
FIGURE 1 .
￿
FceRI-mediated lymphokine expression in mast cell lines . 20 wg RNA (whole cell)
from mast cell clones C1.MC/9, C1.MC/9.2, PT-18, and CI.MC/C57 .1 that had been activated
for4h with antigen plus IgEwere Northern blotted andprobed as listed . Sizes of detected RNA
species are indicated in parentheses . Data for each cytokine represent single Northern blots con-
taining RNA from each cell type listed (except the data forGM-CSF with clone CI.MC/C57 .1
which was obtained from a separate blot) . NT indicates not tested .BURD ET AL .
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FIGURE 2 .
￿
Specificity and regulation ofFccRl-
mediated gene expression in C1.MC/9 . 20 lag
RNA from either resting (unstimulated) cells or
cells cultured for4h with 3 ug/mlIgEanti-DNP
antibody, 10 ng/ml antigen (DNP-HSA), or a
mixture of IgE and antigen were Northern
blotted. In addition, the effects of addition of 2
jug/ml CsA or 10 jig/ml Chxduring the 4-h cul-
ture with antigen plus IgE were evaluated .
The combined data indicate that the MC populations examined were capable of
expressingnumerous cytokine genes and that many ofthese genes exhibit activation-
associated induction via the FceRI pathway.
Signal RequirementsforFceRI-mediated Gene Induction.
￿
We first examined the ability
of individual components of the FceRI-mediated pathway to stimulate gene induc-
tion . For this studywe chose toexamine IL-6, JE, TCA3, MIPla, andMIP10 which
are relatively strongly induced genes in C1.MC/9 . Cells were treated with nothing
(resting), antigen alone, IgE alone, or antigen plus IgE and harvested for Northern
analysis 4 h later (Fig. 2) . Treatment with either antigen or IgE failed to induce
transcription of TCA3, MIPla, or MIPlß, indicating that FceRI engagement by
IgE under noncrosslinking conditions was an insufficient signal for gene induction .
Substantially augmented expression of IL-6 RNA also required both IgE plus an-
tigen, but low levels of IL-6 induction in C1.MC/9 cells were observed with IgE treat-
ment alone . In contrast,JE expression was not significantly enhanced by these treat-
ments . The combined data indicate that, at least for expression ofmost cytokines,
the activating stimulus generated via FceRI requires both engagement of IgE with
its receptor plus binding ofantigen to FceRI-associated IgE . Themechanism respon-
sible for IL-6 induction may be distinct, for as will be indicated below, this gene
is constitutively expressed in anotherMC clone and is relatively resistant to regula-
tion with cyclosporin A (CsA) .
FIGURE 3 .
￿
Effects of alternative signals on
cytokine gene expression . Mast cell clones
C1.MC/C57.1 and C1.MC/9, indicated in
parentheses, were activated for 4 h with ei-
ther nothing (resting), 50 ng/ml PMA, 100
ng/ml A23187, PMAplus A23187, 2.5 tag/ml
Con A, or antigen plus IgE . 20 Itg RNA was
placed on each lane andNorthern blotted with
the indicated probes . The smears in the first
fourTCA3 lanes represent the tails ofanother
probe placed on the same blot but not used
in this study .250
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Regulation of Gene Expression in Mast Cells.
￿
The effects of treatment with the im-
munosuppressive drug CsA and the protein synthesis inhibitor cycloheximide (Chx)
upon IgE plus antigen-mediated gene induction on MC gene induction were also
evaluated. As shown in Fig. 2 CsA co-treatment abolished IgE-mediated gene in-
duction of TCA3, MIPla, MIP10, and JE and partially blocked IL-6 induction.
Similar sensitivitiesto theeffects ofCsA have also been observed for thethree former
genes in T cells (39, 43, and data not shown). However, unlike T cells, induction
of these genes in MC was only partially sensitive to the effects ofChx cotreatment
(Fig. 2).
To examine the nature of the FcERI-mediated signal we investigated the ability
of different agents to mimic signalling via the FceRI in IL-3-dependent C1.MC/9
or IL-3-independent C1.MC/C57.1 cells. We evaluated the ability ofPMA and cal-
cium ionophore treatment to induce lymphokine gene transcription. We alsoexam-
ined the effect ofthe lectin Con A, which can stimulate MC via crosslinking ofcell-
bound IgE and/or cell surface glycoproteins (44, 45). MC cell clones were treated
with PMA (50 ng/ml), calcium ionophore A23187 (100 ng/ml), PMA plus A23187,
or Con A (2.5 wg/ml) in the absence of IgE and harvested for Northern analysis
4 h later. Untreated resting cells and cells stimulated by IgE and antigen were also
examined (Fig. 3). With the exception ofJE, all genes tested were best induced by
IgE plus antigenstimulation (Fig. 3); IL-1 RNA wasnot,detected afterConA, PMA,
or A23187 treatments. Low levels of IL-3 (noted after overexposure ofautoradio-
graph), TCA3, andMIPla RNAwere observed after Con A treatment, but neither
gene was induced by PMA and A23187 treatment. MIPla and MIP10 RNA were
strongly induced by IgE plus antigen but were weakly induced by the action ofCon
A. Afterprolonged exposure ofthe autoradiographsMIP1a andMIPl0 RNAcould
be observed in the groups treated with a combination ofPMA and A23187. PMA
treatment alone induced very low levels ofMIP10 expression (noted on prolonged
autoradiographic exposure) while it downregulated expression of theJE gene (Fig.
3). IL-6 RNA, while present at low levels in unstimulated C1.MC/C57.1 cells, was
augmented by treatment with Con A or with PMA alone, although not to levels
observed for antigen-mediated FceRI crosslinking. No detectable increase in IL-6
RNA above the unstimulated levels was observed after A23187 treatment. In con-
trast, constitutive expressionofJE RNAwasenhanced afterConAactivation (Fig. 3).
Functional Assays of Lymphocyte Production.
￿
We next examined the levels of lym-
phokinebioactivity secretedin response tovarious activating agents (Table I). Cloned
MC lines (C1.MC/9 and C1.MC/C57.1) and primary cultures of IL-3-dependent
BMCMC (>95% MC by light microscopy) obtained from 6-wk BALB/c bone
marrow cultures (see Materials and Methods) were stimulated as indicated (Table
I) and culture supernatants were collected for bioassay at 24 h. RNA expression
studies of BMCMC have not been performed due to the difficulty in obtaining
sufficient quantities of cells. However, supernatants derived from these cells were
analyzed to evaluate directly the relevance ofthe RNAdata to mast cell populations
generated from short term culture.
A marked increase in IL-1 bioactivity was detected in culture supernatants of
C1.MC/9 and in BMCMC in response to stimulation with IgE plus antigen but
was not detectable in supernatants from similarly treated C1.MC/C57.1. The latter
finding is ofinterest in that IL-1 RNA is induced in CL.MC/C57.1 by IgE and an-BURD ET AL.
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TABLE I
Activation ofMC Populations by IgE and Specific Antigen Results in Lymphokine Release
The data represent proliferative responses oflymphokine addicted cell lines (D10.G4 for IL-1 ;
HT-2 for IL-4; TI 165tc for IL-6) expressed as cpm x 103 of thymidine uptake (see Materials
and Methods). IL-1, IL-4, and IL-6 bioactivities were tested at 1 :100, 1 :10, and 1 :40 dilutions
of culture supernatant, respectively. NT indicates not tested.
tigen stimulation (Figs. 1 and 3). As might be expected from the RNA data (Fig.
3), IL-1 bioactivity was not observed in response to Con Atreatment. IL-6 bioac-
tivity wasobserved in the C1.MC/9, C1.MC/C57.1, and BMCMC supernatants after
stimulation with IgE and antigen; IL-6 activity was also detected in supernatants
from the two Con A-stimulated cell lines tested and in unstimulated C1.MC/C57.1
cellsbut not from unstimulated CLMC/9 cells as predicted by the RNA data (Figs.
2 and 3). In addition, C1.MC/9 and CI.MC/C57.1 cells produce low levels ofIL-4
afteractivation with IgEandantigen, but not with ConA. The IL-4-mediated prolifer-
ation could be inhibited with anti-IL-4 antibody (data not shown). The combined
results suggest that signals that induce lymphokine gene expression can also result
in secretion of lymphokine products.
Discussion
SignalingviaFccRIInduces GeneExpression inMC.
￿
In this report we show that specific
stimulation of MG via the Fcc-RI induced gene expression for a wide variety of
cytokines. Ofthe lymphokinestested only IL-2andIL-4were notdetected by Northern
analysis oftotal cellular RNA, yet IL-4 activity was noted in a highly sensitive bio-
assay(Table I). Not all clones were capable ofproducingRNA foreach ofthecytokines
evaluated implying heterogeneity within the population ofin vitro propagated MC
clones. However, some of the differences in cytokine expression may reflect sensi-
tivity differences. Thus, the MC/9 and MC/9.2 were derived from the same parental
clone but CLMC/9.2 consistentlyproduced less cytokine RNA and it appeared that
the group ofcytokinesdetected in C1.MC/9.2 represented a subset ofthose detected
in CLMC/9.
The productionofmultiple cytokines by MC suggests that MC may expressmore
complex functions than the simple effector role originally assigned. The following
cytokines were expressed by at least two independent MC clones: IL-1, IL-3, IL-4,
IL-5, IL-6, IFN-y, andGM-CSFas well asgenes ofa new family ofcytokines (TCA3,
MIPla, MIPIf, and JE). Members of this family of cytokines have been isolated
from T cells (TCA3, MIPla, and MIPI16), macrophages (MIP1a, MIPl0, andJE)
and fibroblasts (JE). Their collective designation as a family has been based upon
a striking conservation of structural similarities including positional conservation
ofcysteine, proline, tyrosine, and phenylalanine residues and a tryptophan-valine-
Treatment IL-1
C1 .MC/9
IL-4 IL-6
C1 .MC/C57 .1
IL-1 IL-4 IL-6
Bone
IL-1
marrow MC
IL-6
Unstimulated 2.4 1 .1 1 .1 2 .5 1 .3 5.9 1.8 0.7
Con A 2.3 1 .4 16 .7 0.1 1 .3 20.3 NT NT
IgE + Ag 30.2 3.1 51 .5 1 .0 6.8 45.1 27.8 41.5
IgE alone NT NT NT NT NT NT 4.3 1.4
Media (no cells) 2.7 1 .4 1 .0 0.7 1 .7 0.2 5.5 1.3252
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glutamine motif(37, 38, 46, 47). Members ofthis family have been shown to possess
pyrogenic activity (48) and to act as chemotactic agents for neutrophils (49) and
monocytes (50). Theirfunction in MC mayrelate to theseproinflammatory proper-
ties. As proposed by Plaut et al. (22), a potential role for the other MC-associated
lymphokines may involve regulation of IgE-mediated allergic responses. IL-3 and
IL-4 are knownto stimulateMC growth andcouldserve as autocrine growth factors
(6-8, 15); IL-1 serves as a cofactor for Th2 cells (51), which release IL-4 and IL-5,
which upregulate IgE production (11, 52), while IFN-,y can have an antagonistic
effect on IgEproduction in vitro (53). IL-5 can also induce theeosinophil prolifera-
tion often associated with allergic responses (52).
The IgE-mediated signals lead to substantially augmented gene induction of all
but one cytokine (JE) and required both FceRIengagement by IgE as well as cross-
linkingby antigen (Fig. 2) . FceRI engagement by IgE alone resulted in weak induc-
tion of only one cytokine gene (IL-6). Generally, Con A-induced only limited in-
creases in gene expression and phorbol ester plus calcium ionophore had a more
limited effect inducing only very low levels of MIPla and MIP10 under the condi-
tions employed in these experiments (Fig. 3) . In contrast, these concentrations of
Con A or phorbol ester plus calcium ionophore usually have equally potent effects
on induction of T cell lymphokine genes (29, 39, 43).
As has been found in T cells (39, 43), induction of TCA3, MIPla, and MIP10
was completely blocked and IL-6 partiallyblocked by CsA co-treatment during IgE
plus antigen-mediated stimulation, suggesting that the regulation of these genes in
MC and T cells may be similar (43, 54). Furthermore, the data imply that CsA
treatment may potentially impair MC-mediated functions relatedto theseproducts.
However, the induction ofthese genes in MG was only partially sensitive to theeffects
of Chx, whereas similar treatments of T cells dramatically diminish gene induction
(data not shown), suggesting that significant differences exist between the cytokine
induction mechanisms regulating expression between T cells and MC.
In addition to the above set of T cell-associated cytokines, MC also produceJE
RNA and IL-1 RNA and bioactivity. These genes have not been generally noted
in T cells, but are associated with multiple other tissue types, including cells of the
monocyte/macrophage lineage. Thus, the MC mayhave the potential for providing
many of the critical cytokines normally associated with distinct immune cell types.
IgE-dependent release of MC mediators may be mimicked by a number of IgE-
independent stimuli, including Con A or phorbol ester and calcium ionophore. Al-
though the molecular mechanism leading to IgE-dependent mediator release has
been shown to depend upon a calcium flux, IgE-independent mediator release ap-
parently can occur via a variety of pathways depending upon the inducing agent
used (reviewed in references 4, 55). Data presented in this study indicate that, when
used under conditions that trigger optimal expression of these genes in T cells(29),
Con A or PMA andA23187 were not sufficient to induce optimal levels oflymphokine
gene expression in either growth factor-dependent or -independent MC lines(Figs.
2 and 3). These results might be interpreted to suggest that the FceRI-mediated
signal is distinct from thosegenerated by calciumflux andPKC translocation. How-
ever, without furtherexaminationof the effects upon gene inductionof different doses
of PMA or A23187, we cannot determine the extent to which cytokine gene induc-
tion can be triggered independently of the FceRI.BURD ET AL.
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Origins andFunctions ofMast Cells.
￿
Based on several lines ofindirect evidence, Burnet
(56) andothers (reviewedin reference 1) suggestedthatthe occurrence of"T cell-de-
pendent" mast cell populations might reflect either the derivation of certain MC
from T cells or the influence ofT cell-derived factor(s) on mast cell proliferation.
The weight of current evidence favors the latter possibility. Nabel et al. (12) and
Galli et al. (13) showed that the supernatants ofcloned Tcells latershown to contain
IL-3 and IL-4(8, 24), promoted the maturation andproliferationofMMC-like cloned
MC that lacked surface structures and function characteristic ofT cells. In addi-
tion, no defects in T cell function have been described in mutant mice genetically
deficient in MC (57) and administration of IL-3 repairs the MMC deficiency of
athymic nude mice (7).
At the first glance, the expression ofmultiple Tcell-associated cytokines by MC
could be regarded as reason to reopen the question ofthe lineage relationship be-
tween MC andTcells. The observation that several ofthese genes can be regulated
byCsA in both cell types is consistentwith this interpretation (Fig. 2). On theother
hand, IL-1,JE, and TNFci are more characteristic ofmonocytes/macrophages than
Tcells, and certain similarities between thenatural historyofMC andmacrophages
have been noted (1, 58). MC, T cells, and monocytes/macrophages all are derived
from hematopoietic precursors. As a result, some overlaps in the patterns of gene
expression inthesepopulationsarenotnecessarilysurprising. Much additional analysis
will be required to determine ifthe pattern ofcytokine production by MC, T cells,
and monocytes will help to clarify lineage relationships among these populations.
As expected based uponthelarge amount ofwork already performed withC1.MC/9
(1, 12, 13), Southern blot analysisdid not reveal TCR (3 chain rearrangement, indi-
cating that this clone does not possess a TCR complex (data not shown).
Although the lineage relationships among MC, T cells, and monocytes are ofin-
terest, adifferent but equally important issue is the cell- and tissue-specific regula-
tion ofcytokine genes in MC vs. T cells and monocytes. Each ofthe cytokine genes
identified in MC in this report haveawide rangeofpotential biological effects, spanning
processes as diverse as hematopoiesis, inflammation, and the regulation ofIgE and
other elementsofimmune responses. We have shown that the transcription ofthese
genes can be significantly modulated by signals transduced by the Fcc-RI after en-
gagement ofreceptor-bound IgE withspecific antigen, andthat this signal alsoresults
in release ofbioactivities attributable to some ofthese cytokines. These findings raise
the interesting possibility that MC may represent a biologically significant source
ofthese cytokines during IgE-dependent and perhaps other responses. Thus, MC
may play an important auxiliary role in regulating inflammatory and immune re-
sponses.
Summary
In response to IgE and specific multivalent antigen, mast cell lines (both growth
factor-dependent and -independent) induce the transcription and/or secretion of
anumberofcytokineshaving a wide spectrum ofactivities. We have identified IL-1,
IL-3, IL-5, IL-6, IFN-y, GM-CSF,JE, MIP1a, MIP10, and TCA3 RNA in at least
twooffourmastcell clones. The production ofthese products (exceptJE) isactivation-
associated and can be induced by IgE plus antigen. In selected instances cytokine254
￿
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expression can also be induced by activation with Con A or phorbol ester plus iono-
phore, albeit to levels less than those observed with IgE plus antigen. In addition,
long-term mast cell clones and primary cultures ofbone marrow-derived mast cells
specifically release IL-1, IL-4, and/or IL-6 bioactivity after activation. These findings
suggest that in addition to their inflammatory effector function mast cells may serve
as a source of growth and regulatory factors. The relationship of mast cells to cells
of the T lymphocyte lineage is discussed.
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